Association between palliative care and end-of-Life care for patients with hematological malignancies
Rattachement africain : us, tw. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
To date, few studies have examined the end-of-life (EOL) care for patients with hematological malignancies (HMs). We evaluated the effects of palliative care on the quality of EOL care and health care costs for adult patients with HMs in the final month of life.We conducted a population-based study and analyzed data from Taiwan's Longitudinal Health Insurance Database, which contains claims information for patient medical records, health care costs, and insurance system exit dates (our proxy for death) between 2000 and 2011.A total of 724 adult patients who died of HMs were investigated. Of these patients, 43 (5.9%) had received only inpatient palliative care (i-Pal group), and 19 (2.6%) received home palliative care (h-Pal group). The mean health care costs during the final month of life were not significantly different between the non-Pal and Pal groups (p=0.315) and between the non-Pal, i-Pal, and h-Pal groups (p=0.293) either. By the multivariate regression model, the i-Pal group had lower risks of chemotherapy, ICU admission, and receipt of CPR, but higher risks of at least two hospitalizations and dying in hospital after adjustments. The h-Pal group had the similar trends as the i-Pal group but lower risk of dying in hospital after adjustments.Patients with HMs who had received palliative care could benefit from less aggressive EOL cancer care in the final month of life. However, 8.6% patients with HMs received palliative care. The related factors of more hospitalizations and dying in hospital warrant further investigation.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Association between palliative care and end-of-Life care for patients with hematological malignancies
- Date Crossref
- 01/10/2019
- Éditeur
- Ovid Technologies (Wolters Kluwer Health)
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Buddhist Tzu Chi Medical Foundation pays non établi dans la noticeOrganisation à but non lucratif
-
Palmetto Hematology Oncology pays non établi dans la noticeÉtablissement de santé
-
Tainan Municipal Hospital Department of Family Medicine pays non établi dans la noticeÉtablissement de santé
-
Dalin Tzu Chi Hospital Department of Family Medicine pays non établi dans la noticeÉtablissement de santé
-
98:40(e17395) pays non établi dans la noticeInstitution
-
Kao YH. Association between palliative care and end-of-Life care for patients with hematological malignancies. Medicine. 2019 Lee YC pays non établi dans la noticeOrganisation à but non lucratif
-
Division of Hematology and Oncology pays non établi dans la noticeInstitution
Buddhist Tzu Chi Medical Foundation, Palmetto Hematology Oncology et Department of Family Medicine — Tainan Municipal Hospital, avec 4 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.